Clinical trials
Heart Failure trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
156 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 9 |
| 2008 | 6 |
| 2009 | 7 |
| 2011 | 6 |
| 2012 | 9 |
| 2013 | 10 |
| 2014 | 11 |
| 2015 | 7 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 10 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 12 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 90 |
| Recruiting | 21 |
| Terminated | 17 |
| Active, not recruiting | 14 |
| Unknown status | 12 |
| No longer available | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 11 |
| Biotronik SE & Co. KG | 8 |
| The Alfred | 8 |
| Medtronic Cardiac Rhythm and Heart Failure | 7 |
| AstraZeneca | 6 |
| Corvia Medical | 6 |
| Monash University | 6 |
| Novo Nordisk A/S | 6 |
| ResMed | 6 |
| Boehringer Ingelheim | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 156 |
| Cardiovascular Diseases | 10 |
| Heart Diseases | 9 |
| Arrhythmias, Cardiac | 6 |
| Atrial Fibrillation | 6 |
| Bradycardia | 6 |
| Cardiomyopathies | 6 |
| Renal Insufficiency, Chronic | 6 |
| Stroke | 6 |
| Heart Failure, Diastolic | 5 |
Trials
Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.
56 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.